Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2026-02-03 @ 11:27 AM
Study NCT ID:
NCT00116961
Status:
COMPLETED
Last Update Posted:
2012-02-07
First Post:
2005-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: